Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Colorectal Phase 1 Trials

Chicago, Illinois

Phase 1 colorectal cancer trials in Chicago, IL

16 Phase 1 colorectal cancer studies are recruiting participants at sites in Chicago as of November 17, 2026, according to ClinicalTrials.gov. Colorectal Phase 1 Trials can help you understand your options and connect with a study team.

Call (888) 415-5976
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Chicago at a glance

  • 16 studies are recruiting at a site in Chicago.
  • By phase: Phase 1 (7), Phase 1/2 (9).
  • By sponsor: industry (12), university, hospital or other (4).
  • Most recent update to one of these records: November 17, 2026.

Studies recruiting in Chicago

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. A Phase 1/2 Study of IAM1363 in HER2 Cancers

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Iambic Therapeutics, Inc
    Study site
    University of Chicago
    Registry record
    NCT06253871 · updated
  2. A Study to Investigate CEA-PRIT 2.0 in Participants With Metastatic Colorectal Cancer (mCRC)

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Hoffmann-La Roche
    Study site
    The University of Chicago Medical Center
    Registry record
    NCT07416552 · updated
  3. SMP-3124LP in Adults With Advanced Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Sumitomo Pharma America, Inc.
    Study sites
    Northwestern Medicine Cancer Center · The University of Chicago
    Registry record
    NCT06526819 · updated
  4. AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Avacta Life Sciences Ltd
    Study site
    The University of Chicago
    Registry record
    NCT07454642 · updated
  5. Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Exelixis
    Study site
    Exelixis Clinical Site #26
    Registry record
    NCT05176483 · updated
  6. PRE-ISPY Phase I/II Oncology Platform Program

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    QuantumLeap Healthcare Collaborative
    Study site
    The University of Chicago Medicine Comprehensive Cancer Center
    Registry record
    NCT05868226 · updated
  7. Manipulation of the Gut Microbiome by a Standardized Preoperative Diet to Prevent Colorectal Cancer Recurrence and Metastasis Following Surgery

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    University of Chicago
    Study site
    University of Chicago
    Registry record
    NCT06349590 · updated
  8. Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

    • Phase 1/2
    • From 12 months, up to 30 years
    • All sexes
    Sponsor
    Children's Oncology Group
    Study site
    Lurie Children's Hospital-Chicago
    Registry record
    NCT04851119 · updated
  9. BMS-986504 in Combination With Pemetrexed for the Treatment of Metastatic Solid Tumors With MTAP Deletion

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Northwestern University
    Study site
    Northwestern University
    Registry record
    NCT07594626 · updated
  10. Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Xencor, Inc.
    Study site
    Xencor Investigative Site
    Registry record
    NCT05433142 · updated
  11. A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Alentis Therapeutics AG
    Study site
    The University of Chicago Medical Center - Oncology
    Registry record
    NCT07169734 · updated
  12. Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    AbbVie
    Study sites
    University of Chicago Medical Center /ID# 276271 · University of Illinois Hospital and Health Sciences System /ID# 251750
    Registry record
    NCT05005403 · updated
  13. A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

    • Phase 1/2
    • Ages 12 and older
    • All sexes
    Sponsor
    Turning Point Therapeutics, Inc.
    Study site
    University of Chicago
    Registry record
    NCT03093116 · updated
  14. A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    858 Therapeutics, Inc.
    Study site
    University of Chicago Medical Center
    Registry record
    NCT06395519 · updated
  15. A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Clasp Therapeutics, Inc.
    Study site
    The University of Chicago Comprehensive Cancer Center
    Registry record
    NCT06778863 · updated
  16. A Study of NX-1607 in Adults With Advanced Malignancies

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Nurix Therapeutics, Inc.
    Study site
    University of Chicago
    Registry record
    NCT05107674 · updated

Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Chicago, IL on ClinicalTrials.gov.

Ask about studies near Chicago

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.

Colorectal Phase 1 Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 415-5976

or send a short form

How should we reach you?

Call